相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive Drug-Class Review Framework for improved evidence-based drug policy and formulary modernization
Mina Tadrous et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2020)
Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries
B. Corbacho et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2020)
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA
Patricia Vella Bonanno et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2019)
The evolution of European HTA and access to innovative medicines
Kate Kolotourou et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2019)
Strategizing health technology assessment for containment of cancer drug costs in a universal health care system: Case of the pan-Canadian Oncology Drug Review
Saroj Niraula
CANCER (2019)
The Confluence of Accelerated Regulatory and Health Technology Assessment Access Pathways
Neil McAuslane et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
Finn Borlum Kristensen et al.
VALUE IN HEALTH (2019)
Evaluating Canadians' Values for Drug Coverage Decision Making
Shirin Rizzardo et al.
VALUE IN HEALTH (2019)
Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries
Nils Wilking et al.
ESMO OPEN (2019)
Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling
Janneke P. C. Grutters et al.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2019)
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group
Sandra Nestler-Parr et al.
VALUE IN HEALTH (2018)
Who's afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic
Olga Loeblova
HEALTH ECONOMICS POLICY AND LAW (2018)
IMPLICATIONS OF GLOBAL PRICING POLICIES ON ACCESS TO INNOVATIVE DRUGS: THE CASE OF TRASTUZUMAB IN SEVEN LATIN AMERICAN COUNTRIES
Andres Pichon-Riviere et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2015)
CHALLENGES FACED IN TRANSFERRING ECONOMIC EVALUATIONS TO MIDDLE INCOME COUNTRIES
Michael Drummond et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2015)
Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces
Steven G. Morgan et al.
BMC HEALTH SERVICES RESEARCH (2013)
Diffusion and use of health technology assessment in policy making: What lessons for decentralised healthcare systems?
Oriana Ciani et al.
HEALTH POLICY (2012)
Health Technology Assessment and Private Payers' Coverage of Personalized Medicine
Julia R. Trosman et al.
JOURNAL OF ONCOLOGY PRACTICE (2011)
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application
Ron Goeree et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2011)
What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability?
Marco Barbieri et al.
VALUE IN HEALTH (2010)
Health Technology Assessment in Canada: 20 Years Strong?
Devidas Mencin et al.
VALUE IN HEALTH (2009)
Key principles for the improved conduct of health technology assessments for resource allocation decisions
Michael F. Drummond et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2008)
Priority setting for health technology assessments: A systematic review of current practical approaches
Hussein Z. Noorani et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2007)
Economic evaluation in the US - What is the missing link?
Peter J. Neumann et al.
PHARMACOECONOMICS (2006)
分享论文
